Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for SunWay Biotech Co., Ltd. (1271:TWSE), powered by AI.
SunWay Biotech Co., Ltd. is currently trading at $64.20. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for SunWay Biotech Co., Ltd. on Alpha Lenz.
View SunWay Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.
“SunWay Biotech Co., Ltd.'s ROE is 3.1%. Explore profitability and growth together.”
Ask for details →SunWay Biotech Co., Ltd. is a biotechnology company specializing in the research, development, and production of health food products. Established in 2007 and headquartered in Taipei, the company’s core offerings include advanced functional ingredients like Monascus purpureus NTU 568 (a patented red yeast product) and Lactobacillus paracasei NTU 101, both of which target digestive health, immune support, and allergy regulation. Its portfolio extends to probiotic-based foods, raw materials, and nutraceutical ingredients used by both consumers and the broader food industry. Operating primarily in the health technology and packaged foods sectors, SunWay Biotech serves domestic and international markets, reflecting Taiwan’s growing presence in the global functional foods industry. The company’s strong focus on innovation and R&D underpins its reputation for scientific excellence, while its financial structure—marked by a high gross margin and low debt—supports its stable position in the competitive biotechnology landscape. SunWay Biotech’s health-oriented products contribute to the expanding sector of preventive healthcare and wellness-driven consumer preferences.
“SunWay Biotech Co., Ltd.'s ROE is 3.1%. Explore profitability and growth together.”
Ask for details →SunWay Biotech Co., Ltd. (ticker: 1271) is a company listed on TWSE in the Consumer Defensive sector (Packaged Foods).
The current price is 64.2 with a P/E ratio of -x and P/B of -x.
ROE is 3.11% and operating margin is 10.48%. Annual revenue is $993M.